Consumer Goods » Food, Beverages & Tobacco | AB-Biotics

AB-Biotics S.A. | Income Statement

Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
818.70
1,632.80
3,450.50
2,922.10
7,207.70
11,892.40
Cost of Goods Sold (COGS) incl. D&A
3,853.40
4,413.80
5,057.60
3,839.80
6,313.50
9,608.40
Gross Income
3,034.70
2,781.00
1,607.10
917.70
894.20
2,284.10
SG&A Expense
80.20
39.50
-
2,976.90
2,030.40
2,079.40
EBIT
3,257.60
2,899.10
1,701.40
3,781.60
1,099.80
563
Unusual Expense
334.30
435.00
175.80
6.00
226.30
-
Non Operating Income/Expense
1,206.40
1,195.40
371.20
1,230.60
571.20
0.60
Interest Expense
208.40
189.90
182.70
258.70
189.70
202.40
Pretax Income
2,529.20
2,274.80
1,314.50
2,796.60
924.20
577.30
Income Tax
716.30
740.00
76.50
3,192.30
29.40
640.90
Consolidated Net Income
1,812.90
1,534.80
1,238.00
5,988.90
894.80
1,218.20
Net Income
1,812.90
1,534.80
1,238.00
5,988.90
894.80
1,218.20
Net Income After Extraordinaries
1,812.90
1,534.80
1,238.00
5,988.90
894.80
1,218.20
Net Income Available to Common
1,812.90
1,534.80
1,238.00
5,988.90
894.80
1,218.20
EPS (Basic)
0.20
0.17
0.14
0.50
0.07
0.10
Basic Shares Outstanding
9,206.50
9,160.60
9,043.90
12,027.60
11,992.40
12,456.30
EPS (Diluted)
0.20
0.17
0.14
0.50
0.07
0.10
Diluted Shares Outstanding
9,206.50
9,160.60
9,043.90
12,027.60
11,992.40
12,456.30
EBITDA
2,559.10
2,128.80
928.00
2,691.90
37.50
1,753.50
Other Operating Expense
142.70
78.60
94.30
113.00
36.40
358.30
Non-Operating Interest Income
64.70
53.80
22.60
19.10
20.40
7.90

About AB-Biotics

View Profile
Address
Esade Creapolis
Barcelona Catalonia 08172
Spain
Employees -
Website http://www.ab-biotics.com
Updated 07/08/2019
AB-Biotics SA engages in the research, development, innovation, and production of biotechnological solutions. It operates through the Probiotics and Genetic Tests business areas. The Probiotics business area offers probiotics for cardiometabolic, oral care, pediatrics, gastrointestinal health, gynaecology and urology, and dermatology and immunology.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.